30 Sep-1 Oct 2021 Nantes (France)

Planning AFIPP2021

Thursday, September 30, 2021 ›
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
›9:00 (1h15)
Human papillomaviruses: Epidemiology
9h00-9h15 Introduction - Christine Clavel (Université de Champagne-Ardennes)
› Salle virtuelle AFIPP2021
›9:00 (15min)
Introduction
Christine Clavel (Université de Champagne-Ardennes)
› Salle virtuelle AFIPP2021
›9:15 (30min)
Current status on vaccine coverage, screening and disease elimination
Laia Bruni (Catalan Institute of Oncology, Barcelona)
› Salle virtuelle AFIPP2021
›9:45 (30min)
HPV and cancer : epidemiological update and worldwide disease burden
Gary Clifford (IARC, Lyon)
› Salle virtuelle AFIPP2021
›10:25 (2h35)
SENTICOL group: new markers for human papillomavirus infections
Ignacio Bravo / Christine Clavel
› Salle virtuelle AFIPP2021
›10:30 (30min)
New biomarkers for diagnosis and follow-up of HPV-induced cancers
Hélène Péré (HEGP, Paris)
› Salle virtuelle AFIPP2021
›11:00 (30min)
NGS technology and data analysis pipeline to analyze HPV integration
Syvlain Baulande (Institut Curie, Paris)
› Salle virtuelle AFIPP2021
›11:30 (30min)
HPV integration hotspots in the RAIDS study
Ivan Bièche et Maud Kamal (Institut Curie, Paris)
› Salle virtuelle AFIPP2021
›12:00 (30min)
Circulating tumor DNA in the RAIDS study
Emmanuelle Jeannot (Institut Curie, Paris)
› Salle virtuelle AFIPP2021
›12:30 (20min)
HPV16 viral load predicts risk of high-grade cervical lesions
Jean-Luc Prétet (Université Bourgogne Franche-Comté)
› Salle virtuelle AFIPP2021
›15:30 (1h)
Human papillomaviruses/polyomaviruses: genetic evolution and diversity
Dorian McIlroy / Antoine Touzé
› Salle virtuelle AFIPP2021
›15:30 (30min)
Evolution and classification of HPVs
Dr Nacho Bravo (CNRS, Montpellier)
› Salle virtuelle AFIPP2021
›16:00 (30min)
Virus Hunting: You can’t always get what you want (HPyVs), but you get HPVs (and more!)
Dr Diana Pastrana (National Cancer Institute, NIH, USA)
› Salle virtuelle AFIPP2021
›16:40 (1h05)
Human papillomaviruses/polyomaviruses: antiviral immunity and vaccination
Dorian McIlroy / Antoine Touzé
› Salle virtuelle AFIPP2021
›16:40 (30min)
First-in-human clinical trial of an SFV-Based RNA replicon cancer vaccine against HPV-induced cancers
Prof. Toos Daemen (University Medical Center Groningen, Pays-Bas)
› Salle virtuelle AFIPP2021
›17:15 (30min)
Antibody responses to Papilloma and Polyoma Viruses
Dr Denise Galloway (Fred Hutchinson Cancer Research Center, Seattle)
› Salle virtuelle AFIPP2021
Session
Speech
Logistics
Break
Tour
Online user: 1 Privacy
Loading...